25 Results | Everything | Search

Product TypeClear Filters

Biochemicals (9)

Small Molecule Modulators (25)

Receptor Pharmacology (2)

Small Molecule Activators (1)

Small Molecule Inhibitors (25)

Acetyltransferases (1)

Chromatin Reader Interactions (2)

Demethylases (2)

Glycerolipid Lipases (1)

Kinases (6)

Methyltransferases (1)

Peptidases & Proteases (1)

TNF-α/NF-κB Signaling (1)

Negative Controls (25)

Transporter & Exchanger Modulators (1)

Research AreaClear Filters

Cancer (6)

Cell Biology (9)

Endocrinology & Metabolism (1)

Epigenetics, Transcription, & Translation (12)

Immunology & Inflammation (8)

Infectious Disease (2)

Lipid Biochemistry (3)

Neuroscience (2)

ApplicationClear Filters

Enzyme Activity (1)

Displaying 1 - 25 of 25 Results

(R)-MG132

An inactive diastereomer of MG132

CAS No. 1211877-36-9

Item No. 13697

Formulation: A crystalline solid

Purity: ≥95%

Cbz-L-Leu-D-Leu-L-Leucinal

1 mg

$53

Add

5 mg

$251

Add

10 mg

$423

Add

25 mg

$924

Add

GSK-J5 (hydrochloride)

A negative control compound for GSK-J4

CAS No. 1797983-32-4

Item No. 12074

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$40

Add

5 mg

$143

Add

10 mg

$246

Add

50 mg

$1,030

Add

GSK106 (hydrochloride)

An inactive control for GSK484 and GSK199

CAS No. 1652591-82-6

Item No. 17490

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$41

Add

1 mg

$75

Add

5 mg

$312

Add

10 mg

$544

Add

Cyclic di-UMP (sodium salt)

A pyrimidine-containing CDN

Item No. 33890

Formulation: A solid

Purity: ≥95%

c-di-UMP
c-UpUp
Cyclic di-Uridine monophosphate
3’3’-Cyclic UMP-UMP

600 µg

$267

Add

SB 202474

A negative control for SB 202190 and SB 203580

CAS No. 172747-50-1

Item No. 18749

Formulation: A solid

Purity: ≥97%

1 mg

$156

Add

MI-nc (hydrochloride)

A negative control for MI-2

CAS No. 1934302-23-4

Item No. 11621

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$69

Add

5 mg

$233

Add

10 mg

$427

Add

25 mg

$983

Add

Nullscript

A negative control for scriptaid

CAS No. 300816-11-9

Item No. 16433

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$75

Add

5 mg

$333

Add

10 mg

$589

Add

U-0124

An inactive analog of U-0126

CAS No. 108923-79-1

Item No. 34871

Formulation: A solid

Purity: ≥95%

500 µg

$95

Add

1 mg

$167

Add

PHGDH-inactive

A negative control for NCT-502 and NCT-503

CAS No. 1914971-16-6

Item No. 19717

Formulation: A crystalline solid

Purity: ≥98%

3-Phosphoglycerate Dehydrogenase-inactive

1 mg

$54

Add

5 mg

$238

Add

10 mg

$418

Add

25 mg

$913

Add

GSK-J2 (sodium salt)

A negative control compound for GSK-J1

CAS No. 2108665-15-0

Item No. 12056

Formulation: A crystalline solid

Purity: ≥90%

1 mg

$40

Add

5 mg

$143

Add

10 mg

$246

Add

50 mg

$1,030

Add

KC02

A negative control for KC01, an ABHD16A inhibitor

CAS No. 1646795-60-9

Item No. 17365

Formulation: A 1 mg/ml solution in ethyl acetate

Purity: ≥98%

100 µg

$49

Add

500 µg

$202

Add

1 mg

$329

Add

(S)-PFI-2 (hydrochloride)

Negative control of (R)-PFI 2

CAS No. 1627607-88-8

Item No. 18119

Formulation: A crystalline solid

Purity: ≥95%

(+)-PFI-2

1 mg

$36

Add

5 mg

$103

Add

10 mg

$186

Add

Retreversine

An inactive isomer of reversine

CAS No. 1028332-91-3

Item No. 10006606

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$40

Add

1 mg

$73

Add

5 mg

$302

Add

10 mg

$525

Add

ABC34

A negative control for JJH260, an AIG1 inhibitor

CAS No. 1831135-56-8

Item No. 19385

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$107

Add

1 mg

$203

Add

5 mg

$949

Add

XY1

A negative control for SGC707

CAS No. 1624117-53-8

Item No. 17518

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$117

Add

10 mg

$218

Add

25 mg

$514

Add

50 mg

$909

Add

UNC1079

A negative control for L3MBTL3 domain inhibition

CAS No. 1418741-86-2

Item No. 20566

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$49

Add

5 mg

$190

Add

10 mg

$329

Add

25 mg

$702

Add

MOZ-IN-2

An inactive derivative of WM-1119

CAS No. 2055397-88-9

Item No. 27686

Formulation: A solid

Purity: ≥98%

WM-2474

1 mg

$32

Add

5 mg

$94

Add

10 mg

$172

Add

25 mg

$388

Add

(S)-DO271

An inactive control for DO264

CAS No. 2301865-01-8

Item No. 30038

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$36

Add

1 mg

$63

Add

5 mg

$253

Add

UNC7145

An inactive derivative of UNC6934

CAS No. 2561494-78-6

Item No. 40166

Formulation: A solid

Purity: ≥98%

1 mg

$31

Add

5 mg

$124

Add

10 mg

$216

Add

TH263

An inactive analog of TH257

CAS No. 313520-94-4

Item No. 37295

Formulation: A solid

Purity: ≥98%

5 mg

$96

Add

10 mg

$173

Add

25 mg

$288

Add

50 mg

$478

Add

PKCε Inhibitor Scramble Peptide

A negative control for PKCε inhibitor peptide

CAS No. 813416-34-1

Item No. 31761

Formulation: A lyophilized solid

Purity: ≥95%

H-Leu-Ser-Glu-Thr-Lys-Pro-Ala-Val-OH
H-LSETKPAV-OH

1 mg

$63

Add

OICR-0547

An inactive derivative of OICR-9429

CAS No. 1801873-49-3

Item No. 18180

Formulation: A solid

Purity: ≥95%

1 mg

$32

Add

5 mg

$136

Add

10 mg

$192

Add

Dnp-GPLG

A negative control for use in MMP activity assays

Item No. 24705

Formulation: A lyophilized powder

Purity: ≥95%

Dnp-Gly-Pro-Leu-Gly-OH
Matrix Metalloproteinase Substrate II Control
MMP Substrate II Control

1 mg

$90

Add

PS-47

An inactive derivative of PS-48

CAS No. 1180676-33-8

Item No. 41116

Formulation: A solid

Purity: ≥95%

50 mg

$116

Add

100 mg

$185

Add

250 mg

$260

Add

500 mg

$462

Add

GSK8573

An inactive derivative of GSK2801

CAS No. 1693766-04-9

Item No. 43560

Formulation: A solid

Purity: ≥98%

1 mg

$32

Add

5 mg

$96

Add

10 mg

$160

Add

25 mg

$280

Add

Displaying 1 - 25 of 25 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥97%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥90%

Formulation: A 1 mg/ml solution in ethyl acetate

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A lyophilized solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A lyophilized powder

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%